BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 165 filers reported holding BIOLIFE SOLUTIONS INC in Q1 2022. The put-call ratio across all filers is 6.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,109,850 | -37.4% | 80,367 | +0.1% | 0.00% | -50.0% |
| Q2 2023 | $1,773,547 | +93244.6% | 80,251 | -8.1% | 0.00% | 0.0% |
| Q1 2023 | $1,900 | +26.3% | 87,348 | +5.7% | 0.00% | 0.0% |
| Q4 2022 | $1,504 | -99.9% | 82,631 | +5.1% | 0.00% | -33.3% |
| Q3 2022 | $1,788,000 | +79.5% | 78,592 | +9.0% | 0.00% | +200.0% |
| Q2 2022 | $996,000 | +21.0% | 72,112 | +99.2% | 0.00% | 0.0% |
| Q1 2022 | $823,000 | -57.6% | 36,198 | -30.5% | 0.00% | -50.0% |
| Q4 2021 | $1,941,000 | -23.3% | 52,072 | -12.9% | 0.00% | -33.3% |
| Q3 2021 | $2,530,000 | +146.8% | 59,794 | +159.7% | 0.00% | +200.0% |
| Q2 2021 | $1,025,000 | +103.8% | 23,027 | +64.8% | 0.00% | 0.0% |
| Q1 2021 | $503,000 | -7.5% | 13,972 | +2.5% | 0.00% | 0.0% |
| Q4 2020 | $544,000 | +68.9% | 13,637 | +22.7% | 0.00% | 0.0% |
| Q3 2020 | $322,000 | – | 11,112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 7,566,292 | $171,982,000 | 7.71% |
| Gagnon Advisors, LLC | 205,968 | $4,682,000 | 2.16% |
| Ranger Investment Management | 1,300,407 | $29,558,000 | 1.87% |
| GAGNON SECURITIES LLC | 379,506 | $8,626,000 | 1.41% |
| Zweig-DiMenna Associates LLC | 376,550 | $8,559,000 | 1.14% |
| Meros Investment Management, LP | 48,504 | $1,102,000 | 0.87% |
| Mesirow Financial Investment Management, Inc. | 10,526 | $239,000 | 0.81% |
| Penbrook Management LLC | 48,615 | $1,105,000 | 0.72% |
| MOODY ALDRICH PARTNERS LLC | 220,680 | $5,016,000 | 0.70% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,456,656 | $33,110,000 | 0.64% |